www.reacta2024.org Open in urlscan Pro
35.156.117.131  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * About REACTA 2024
 * Agenda
 * Speakers
 * Abstracts
 * Venue/Travel Information
 * …  
   * About REACTA 2024
   * Agenda
   * Speakers
   * Abstracts
   * Venue/Travel Information


 * About REACTA 2024
 * Agenda
 * Speakers
 * Abstracts
 * Venue/Travel Information
 * …  
   * About REACTA 2024
   * Agenda
   * Speakers
   * Abstracts
   * Venue/Travel Information

 * 

Registration
 * About REACTA 2024
 * Agenda
 * Speakers
 * Abstracts
 * Venue/Travel Information
 * …  
   * About REACTA 2024
   * Agenda
   * Speakers
   * Abstracts
   * Venue/Travel Information


 * About REACTA 2024
 * Agenda
 * Speakers
 * Abstracts
 * Venue/Travel Information
 * …  
   * About REACTA 2024
   * Agenda
   * Speakers
   * Abstracts
   * Venue/Travel Information

 * 

Registration



 * 2024
   
   
   REACTA
   
   
   FOR TRENDS AND UPDATES IN CLINICAL TRIALSACROSS ASIA.
   
   
   Register Now


 * ABOUT REACTA 2024
   
   DATE: AUGUST 2-3, 2024
   
   VENUS: TAIPEI MEDICAL UNIVERSITY SHAUNG HO CAMPUS
   
    
   
   THE REGIONAL ASIAN CLINICAL TRIAL ASSOCIATION (REACTA) WAS LAUNCHED IN 2013
   BY TAIPEI MEDICAL UNIVERSITY AND CLINICAL RESEARCH CENTERS OF EXCELLENCE IN
   JAPAN, KOREA, AND MALAYSIA. AIMING TO COMBINE EXPERTISE IN CLINICAL TRIAL,
   REACTA CREATES A PLATFORM TO PROMOTE KNOWLEDGE EXCHANGE AND INTERNATIONAL
   COLLABORATION IN CLINICAL TRIALS ACROSS ASIA.
   
    
   
   REACTA 2024, TAKING PLACE ON 2 – 3 AUGUST IN TAIPEI, WILL SHOWCASE KEY
   ACHIEVEMENTS OF CLINICAL TRIALS ACROSS TAIWAN, JAPAN, KOREA, MALAYSIA AND THE
   WIDER ASIA REGION, WITH FOCUSES ON THE INTRODUCTION OF NEW TECHNOLOGIES AND
   APPLICATION OF AI TO TRIAL IMPLEMENTATION IN THE DIGITAL ERA.


 * FORUM INFORMATION
   
   THEME 
   
   FROM IDEATION TO VALIDATION: CLINICAL TRIALS IN THE DIGITAL ERA
   
    
   
   TOPICS OF SESSIONS
   
    1. CLINICAL TRIALS IN THE DIGITAL AGE
    2. FUTURE OF DECENTRALISED CLINICAL TRIALS (DCT)
    3. UPDATES ON LATEST REGULATIONS AND MANAGEMENT PRACTICES ON CLINICAL TRIALS
    4. EXPERIENCE SHARING OF KEY CLINICAL TRIAL STUDIES IN TAIWAN AND IN ASIA
    5. RESEARCH INNOVATION & CLINICAL VALIDATION: THE JOURNEY
    6. INTERNATIONAL COLLABORATIVE TRIALS: OPPORTUNITIES AND CHALLENGES

 * REACTA 2024
   
   
   02-03 AUGUST @TAIPEI MEDICAL UNIVERSITY SHAUNG HO CAMPUS
   
   From Ideation to Validation:
   
   Clinical Trials in the Digital Era
   
    
   
   Register Now!
   
   


 * ABOUT REACTA 2024
   
    
   
   
   THE REGIONAL ASIAN CLINICAL TRIAL ASSOCIATION (REACTA) WAS LAUNCHED IN 2013
   BY TAIPEI MEDICAL UNIVERSITY AND CLINICAL RESEARCH CENTERS OF EXCELLENCE IN
   JAPAN, KOREA, AND MALAYSIA. AIMING TO COMBINE EXPERTISE IN CLINICAL TRIAL,
   REACTA CREATES A PLATFORM TO PROMOTE KNOWLEDGE EXCHANGE AND INTERNATIONAL
   COLLABORATION IN CLINICAL TRIALS ACROSS ASIA.
   
    
   
   
   REACTA 2024, TAKING PLACE ON 2 – 3 AUGUST IN TAIPEI, WILL SHOWCASE KEY
   ACHIEVEMENTS OF CLINICAL TRIALS ACROSS TAIWAN, JAPAN, KOREA, MALAYSIA AND THE
   WIDER ASIA REGION, WITH FOCUSES ON THE INTRODUCTION OF NEW TECHNOLOGIES AND
   APPLICATION OF AI TO TRIAL IMPLEMENTATION IN THE DIGITAL ERA.
   
   
   


 * FORUM INFORMATION
   
   
   THEME 
   
   
   TOPICS OF SESSIONS
   
   
   FROM IDEATION TO VALIDATION: CLINICAL TRIALS IN THE DIGITAL ERA
   
    * Clinical trials in the digital age
    * Future of decentralised clinical trials (DCT)
    * Updates on latest regulations and management practices on clinical trials
    * Experience sharing of key clinical trial studies in Taiwan and in Asia
    * Research innovation & clinical validation: the journey
    * International collaborative trials: opportunities and challenges
   
   


 * CONTACT US
   
   Name
   Email
   Message
   
   Submit
   Comment
   
   
   
   
   Organizers
   
   




2024 REACTA TW




Home
Register




Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume
you accept the use of cookies.
Accept
Learn More